Data Leak Shows Regulators Had Major Concerns About Pfizer’s mRNA Vaccine

Leaked documents show that some early commercial batches of Pfizer-BioNTech’s COVID-19 vaccine had lower than expected levels of intact mRNA, prompting wider questions about how to assess this novel vaccine platform.